Daniel Wagner

Daniel Wagner

Director/Board Member at
New Haven Pharmaceuticals, Inc.
55 year
Health Technology
Health Services
Consumer Services

Profile

Daniel Wagner is currently a Senior Managing Director at Connecticut Innovations, Inc. He is also a Director at Biorez, Inc., SAMI Health, Inc., New Haven Pharmaceuticals, Inc., AlloMek Therapeutics LLC, and Tangen Biosciences, Inc. In the past, he served as a Director at RemoteReality Corp., FMP Products, Inc., EpiEP, Inc., CMDBioscience, Inc., Innovatient Solutions, Inc., P2 Science, Inc., Synbody Biotechnology, Inc., IsoPlexis Corp., Azitra, Inc., and CuraGen Corp.
Mr. Wagner obtained his undergraduate degree from Quinnipiac University in 2000 and his MBA in 2005.
He also holds an undergraduate degree from the University of Dayton.

Daniel Wagner active positions

CompaniesPositionStart
Private Equity Investor 2007-10-31
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member 2015-11-30
Director/Board Member -

Former positions of Daniel Wagner

CompaniesPositionEnd
ISOPLEXIS CORPORATION Director/Board Member 2023-03-20
AZITRA, INC. Director/Board Member -
Director/Board Member -
░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Daniel Wagner's experience

Training of Daniel Wagner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Process Industries

Health Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology